Position in OGI
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$905,818
-$363,751 QoQ
Shares Held
888,057
-6.3% QoQ
Ownership
0.616%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#3
of 69 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AdvisorShares Investments LLC holds $261,923,894 across 17 Drug Manufacturers - Specialty & Generic names. OGI ranks #10 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CURLF |
Curaleaf Holdings, Inc.
|
12,420,961 | $134,270,588 | |
| 2 | TRLV |
Trulieve Cannabis Corp.
|
10,641,152 | $104,602,524 | |
| 3 | GLAS |
Glass House Brands Inc.
|
850,000 | $11,050,000 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
11,553 | $1,947,142 | |
| 5 | ALKS |
Alkermes plc.
|
36,438 | $1,909,351 | |
| 6 | CRON |
Cronos Group Inc.
|
482,394 | $1,341,055 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
27,618 | $1,284,513 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,883 | $1,114,076 |
All Filings in OGI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $905,818 | 888,057 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,269,569 | 947,440 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,720,587 | 1,024,159 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,136,359 | 1,052,394 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,083,231 | 802,394 | Shares | Sole | 2025-08-04 | |
| No filing history on record for this holder in this stock. | ||||||